Muscle-specific E3 ubiquitin ligases MuRF1 and Atrogin-1 are notably upregulated during the onset and progression of cancer cachexia, with inflammation playing a pivotal role in the development of muscle atrophy in cachexia. Here, FBXO32 is linked to muscle atrophy.